Efficacy and safety of bimekizumab in moderate to severe hidradenitis suppurativa: a phase 2, double-blind, placebo-controlled randomized clinical trial

S Glatt, GBE Jemec, S Forman, C Sayed… - JAMA …, 2021 - jamanetwork.com
Importance Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a high
burden for patients and limited existing therapeutic options. Objective To evaluate the …
被引用次数：125 相关文章

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial

S Glatt, GBE Jemec, S Forman… - JAMA …, 2021 - researchinformation.amsterdamumc …
Importance: Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a high
burden for patients and limited existing therapeutic options. Objective: To evaluate the …

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial

S Glatt, GBE Jemec, SB Forman, C Sayed… - JAMA …, 2021 - dialnet.unirioja.es
Importance Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a high
burden for patients and limited existing therapeutic options. Objective To evaluate the …
[HTML] nih.gov

[HTML][HTML] Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial

S Glatt, GBE Jemec, S Forman, C Sayed… - JAMA …, 2021 - ncbi.nlm.nih.gov
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial

S Glatt, GBE Jemec, S Forman, C Sayed… - JAMA …, 2021 - pubmed.ncbi.nlm.nih.gov
Importance Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a high
burden for patients and limited existing therapeutic options. Objective To evaluate the …

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.

S Glatt, GBE Jemec, S Forman, C Sayed… - JAMA …, 2021 - europepmc.org
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase
2, Double-blind, Placebo-Controlled Randomized Clinical Trial. - Abstract - Europe PMC Sign in …

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.

S Glatt, GBE Jemec, S Forman, C Sayed… - JAMA …, 2021 - europepmc.org
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase
2, Double-blind, Placebo-Controlled Randomized Clinical Trial. - Abstract - Europe PMC Sign in …